Vertex Hopes to Channel CF Drug Successes into Other Therapies in the Pipeline

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 30, 2021 at 11:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Boston, Mass.-based Vertex Pharmaceuticals said in a second-quarter earnings call on Thursday that its revenue has increased 18% compared with Q2 2020, a rise solely driven by the company's six cystic fibrosis (CF) drugs.

    article source